Lipolytic sensitivity and response to fasting in normotensive and hypertensive obese humans

Metabolism: Clinical and Experimental

Volumn 46, Issue 9, 1997, Pages 1080-1084

  Townsend, Raymond R ^a   Klein, Samuel ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; GLYCEROL;

ADULT; ARTICLE; BODY MASS; CALORIMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DOWN REGULATION; GLYCEROL BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIPOLYSIS; METABOLIC DISORDER; OBESITY; PRIORITY JOURNAL;

EID: 0030866916     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90282-1     Document Type: Article

References (30)

1. Peiris AN, Hennes MI, Evans DJ, et al: Relationship of anthropometric measurements of body fat distribution to metabolic profile in premenopausal women. Acta Med Scand Suppl 723:179-188, 1988
2. Kissebah AH, Peiris ANB: Biology of regional body fat distribution: Relationship to non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 5:83-109, 1989
3. Bray GA: Complications of obesity. Ann Intern Med 103:1052-1062, 1985
4. Arner P: Control of lipolysis and its relevance to development of obesity in man. Diabetes Metab Rev 4:507-515, 1988
5. Wolfe RR, Peters EJ, Klein S, et al: Effect of short-term fasting on lipolytic responsiveness in normal and obese human subjects. Am J Physiol 252:E189-E196, 1987
6. Jensen MD: Regulation of forearm lipolysis in different types of obesity. In vivo evidence for adipocyte heterogeneity. J Clin Invest 87:187-193, 1991
7. Weidmann P, De Courten M, Boehlen L, et al: The pathogenesis of hypertension in obese subjects. Drugs 46:197-209, 1993 (suppl 2)
8. Modan M, Halkin H: Hyperinsulinemia or increased sympathetic drive as links for obesity and hypertension. Diabetes Care 14:470-487, 1991
9. Landsberg L: The sympathoadrenal system, obesity and hypertension: An overview. J Neurosci Methods 34:179-186, 1990
10. DeFronzo RA, Ferrannini E: Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
11. Townsend RR, Klein S, Wolfe RR: Changes in lipolytic sensitivity following repeated epinephrine infusion in humans. Am J Physiol 266:E155-E160, 1994
12. Stewart WK, Fleming LW: Features of a successful therapeutic fast of 382 days' duration. Postgrad Med J 49:203-209, 1973
13. Technology Assessment Conference Panel: Methods for voluntary weight loss and control: Technology Assessment Conference Statement. Ann Intern Med 116:942-949, 1992
14. Klein S, Young VR, Blackburn GL, et al: The impact of body composition on the regulation of lipolysis during short-term fasting. J Am Coll Nutr 7:77-84, 1988
15. Jensen MD, Haymond MW, Gerich JE, et al: Lipolysis during fasting. J Clin Invest 79:207-213, 1987
16. McGuire EAH, Helderman JH, Tobin JD, et al: Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 41:565-573, 1976
17. Hussain MN, Benedict CR: Radioenzymatic microassay for simultaneous estimations of dopamine, norepinephrine, and epinephrine in plasma, urine, and tissues. Clin Chem 31:1861-1864, 1985
18. Koller M: Results for 74 substances tested for interference with determination of plasma catecholamines by "high-performance" liquid chromatography with electrochemical detection. Clin Chem 34:947-949, 1988
19. McDonald-Gibson RG, Young M: The use of an automatic solids injection system for quantitative determination of plasma long chain non-esterified fatty acids by gas-liquid chromatography. Clin Chim Acta 53:117-126, 1974
20. Wolfe RR: Termination of isotopic enrichment by gas chromatography-mass spectroscopy, in Wolfe RR (ed): Radioactive and Stable Isotope Tracers in Biomedicine. New York, NY, Wiley-Liss, 1992, pp 49-86
21. Steele R, Wall J, DeBodo R, et al: Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187:15-24, 1956
22. Steele R: Influences of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 82:420-430, 1959
23. Jecquier E: Measurement of energy expenditure in clinical nutritional assessment. JPEN 11:86S-89S, 1987 (suppl)
24. Landsberg L: Insulin resistance, energy balance and sympathetic nervous system activity. Clin Exp Hypertens [A] 12:817-830, 1990
25. Paffenbarger RS Jr, Thorne MC, Wing AL: Chronic disease in former college students. VIII. Characteristics in youth predisposing to hypertension in later years. Am J Epidemiol 88:25-32, 1968
26. Rose HG, Yalow RS, Schweitzer P, et al: Insulin as a potential factor influencing blood pressure in amputees. Hypertension 8:793-800, 1986
27. Ferrannini E, Buzzigoli G, Bonadonna R, et al: Insulin resistance in essential hypertension. N Engl J Med 317:350-357, 1987
28. Arner P, Bolinder J, Engfeldt P, et al: The antilipolytic effect of insulin in human adipose tissue in obesity, diabetes mellitus, hyperinsulinemia, and starvation. Metabolism 8:753-760, 1981
29. Modan M, Halkin H, Almog S, et al: Hyperinsulinemia. A link between hypertension, obesity and glucose intolerance. J Clin Invest 75:809-817, 1985
30. Rowe JW, Young JB, Minaker KL, et al: Effect of insulin and glucose infusion on sympathetic nervous system activity in normal man. Diabetes 30:219-225, 1981